Headline

Consultant @ ClearView HCP | Ex-IQVIA | Ex-Zinnov | Growth Strategy and Operations

About

Pharma strategy and business transformation professional with 7.5 years across commercial strategy, new product planning (NPP/NPI), portfolio management, GTM strategy and business strategy. Proven track record of translating complex data into actionable recommendations that drive financial growth and long-term strategic value for Fortune 500 clients. Targeting high-impact roles in corporate strategy, NPI/NPP, business partner strategy, and commercial insights roles at pharma MNCs and GCCs within a global consulting environment.

Location

Gurugram

Work experience

Consultant at ClearView Healthcare Partners, Mar 2025 - Present · 1 yr 5 mos, Gurugram, • M&A Opportunity Assessment & BD Prioritization for a G500 MNC evaluating inorganic growth options: Conducted six company analog due diligence benchmarking sales force, promotional spend, and market access requirements to assess build-vs buy implications and prioritize target areas for asset acquisition and in-licensing • Market Entry and Competitive Pricing Strategy for a late-stage asset across Europe: Conducted competitor benchmarking, modeled market disruption and new entrant scenarios, and developed scenario-based strategic recommendations to optimize revenue and market positioning at launch • Growth and Portfolio Strategy for a client product across US and Europe: Developed a multi-wave growth roadmap; applied structured prioritization across 50+ opportunities, conducted expert interviews, built market sizing models, and synthesized competitive and operational trade-offs to identify top strategic bets

Associate Consultant at IQVIA, May 2022 - Oct 2024 · 2 yrs 6 mos, Bengaluru, • M&A Buy-Side Strategic Due Diligence: Conducted a rigorous three-week due diligence to evaluate the revenue potential of the target company in Italy, aligning findings with management's budgeting and planning objectives. Delivered comprehensive insights into the target's historical performance, market positioning in Italy, and potential commercial opportunities across prescription and consumer product portfolios, facilitating informed decision-making and strategic planning • Commercial Opportunity Assessment & Revenue Forecasting: Built bottom-up revenue model forecasting $1B+ by 2036 across the US, Europe, and China; conducted analogue analysis and stakeholder interviews with industry experts and policymakers • Value & Investment Case Design – Inorganic Growth Strategy: Identified and prioritized 13 potential assets and 3 companies for a European multinational's growth, evaluating revenue potential and strategic fit • Brand Positioning & Revenue Forecasting across EU, Japan and China: Developed value proposition and strategic brand positioning, forecasted topline revenues, and identified market penetration opportunities • Pricing and Market Access Strategy across 10 emerging markets: Evaluated market access pathways and competitive pricing and launch strategies to optimize commercial performance for new product launches • Market Expansion Strategy into Central and Eastern Europe: Analyzed competitive dynamics, access pathways, and competitive and regulatory precedents to optimize regional market entry

External Consultant at Auctus Advisors, Jan 2022 - Apr 2022 · 4 mos, Remote, JV Implementation & Financial Viability Assessment: Led strategic planning and financial modeling for the successful implementation of a new JV between a prominent Infrastructure conglomerate and an FMCG brand

Management Consultant at Zinnov, Jun 2017 - Sep 2019 · 2 yrs 4 mos, Bengaluru Area, India

Education

Bachelor’s Degree, Vellore Institute of Technology

Intermediate, CBSE, Vidya Mandir Senior Secondary School